Silence Therapeutics Plc (SLNCF)

4.00 0.00 (0.00%) USD  |  OTCM  |  Aug 25, 16:00
More

Silence Therapeutics EPS Estimates for 2 Fiscal Years Ahead

EPS Estimates for 2 Fiscal Years Ahead Chart

View EPS Estimates for 2 Fiscal Years Ahead for SLNCF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Estimates for 2 Fiscal Years Ahead Chart
Start Trial

Historical EPS Estimates for 2 Fiscal Years Ahead Data

View and export this data back to 2022. Start Trial.
Date Value
August 10, 2026 --
February 27, 2025 --
November 14, 2024 --
November 14, 2023 --
August 16, 2023 --
May 18, 2023 --
Date Value
May 17, 2023 --
May 08, 2023 --
March 28, 2023 --
August 17, 2022 --
May 16, 2022 --
March 17, 2022 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for 2 Fiscal Years Ahead Range, Past 5 Years

View EPS Estimates for 2 Fiscal Years Ahead Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Estimates for 2 Fiscal Years Ahead Benchmarks

View EPS Estimates for 2 Fiscal Years Ahead Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc Upgrade
NuCana Plc Upgrade
Mereo BioPharma Group Plc Upgrade
Compass Pathways Plc Upgrade
HemoGenyx Pharmaceuticals Plc --